Skip to main content

Infectious Diseases and Therapy

Ausgabe 4/2024

Inhalt (21 Artikel)

Open Access Brief Report

Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT)

Olga Sánchez-Soliño, Ryan D. Kilpatrick, Christopher Johnson, Yixin Fang, Yizhou Ye, Negar Niki Alami, Katarzyna Zarish, Whitney S. Krueger, Nancy Dreyer, Gregory C. Gray

Open Access Case Report

Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

Alexy Inciarte, Lorena de la Mora, Emilio Huaier-Arriazu, Berta Torres, Silvia Cañizares, Elizabeth Zamora, Montserrat Laguno, Ana Gonzalez-Cordón, Alberto Foncillas, Ivan Chivite, Júlia Calvo, Juan Ambrosioni, Esteban Martínez, Jose Luis Blanco, J. M. Miro, Maria Martinez-Rebollar, Josep Mallolas

Open Access Commentary

Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines

Ann R. Falsey, Stefania Maggi, Tor Biering-Sørensen

Open Access Original Research

Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia

Nada K. Alhumaid, Areej M. Alajmi, Nada F. Alosaimi, Maryam Alotaibi, Thamer A. Almangour, Majed S. Nassar, Ziad A. Memish, Abdulwahab Z. Binjomah, Ahmed Al-Jedai, Abdulaziz S. Almutairi, Saeed Algarni, Noura M. Alshiban, Munirah S. Aleyiydi, Abdulkader F. Tawfik, Atef Shibl, Essam A. Tawfik

Open Access Original Research

Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey

Jennie H. Best, Mitra Sadeghi, Xiaowu Sun, Arpamas Seetasith, Lisa Albensi, Seema Joshi, Marcus J. Zervos

Open Access Original Research

Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination

Timothy E. Albertson, Caitlin Hansen, Smiti Bihari, Juleen Gayed, Xia Xu, J. Abraham Simón-Campos, Michael E. Dever, Jose F. Cardona, Essack Mitha, Jeffrey B. Baker, Georgina Keep, Islamiat Oladipupo, Federico J. Mensa, Ye Feng, Hua Ma, Kenneth Koury, Susan Mather, Claudia Ana Ianos, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, William C. Gruber, Alejandra Gurtman, Charu Sabharwal, Nicholas Kitchin

Open Access Original Research

K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact

Carolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, Mariana Chumbita, Rosario Menendez, Aina Mateu-Subirà, Olivier Peyrony, Patricia Monzó, Carlos Lopera, Antonio Gallardo-Pizarro, Raúl Méndez, Esther Calbo, Mariona Xercavins, Genoveva Cuesta-Chasco, José A. Martínez, Ma Angeles Marcos, Josep Mensa, Alex Soriano

Open Access Original Research

Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study

Zhikai Wan, Junwei Su, Xueling Zhu, Xiang Liu, Yongzheng Guo, Dairong Xiang, Xiaotang Zhou, Xiaorong Peng, Ran Tao, Qing Cao, Guanjing Lang, Ying Huang, Biao Zhu

Open Access Original Research

Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions

Mark H. Rozenbaum, Erica Chilson, Raymond Farkouh, Liping Huang, Alejandro Cane, Adriano Arguedas, Maria J. Tort, Vincenza Snow, Ahuva Averin, Derek Weycker, Dhwani Hariharan, Mark Atwood

Open Access Original Research

Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia

Ru Han, Peter San Martin, Nurilign Ahmed, Adriana Guzman-Holst, Ahmed Mohy, Thatiana Pinto, Bruna de Veras, Jorge A. Gomez, Gyneth Lourdes Bibera, Désirée A. M. van Oorschot

Open Access Original Research

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework

Sushma Kavikondala, Katrin Haeussler, Xuan Wang, Mary T. Bausch-Jurken, Maria Nassim, Nitendra Kumar Mishra, Mia Malmenäs, Pawana Sharma, Nicolas Van de Velde, Nathan Green, Ekkehard Beck

Open Access Original Research

Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study

Yu-Yuan Wang, Wei-Wen Zhang, Ze-xi Lu, Jia-lin Sun, Ming-xia Jing

Open Access Original Research

Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States

Daniel Molnar, Elizabeth M. La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran

Open Access Original Research

Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019

Aleksandra Polkowska-Kramek, Elizabeth Begier, Robin Bruyndonckx, Caihua Liang, Caroline Beese, Gordon Brestrich, Thao Mai Phuong Tran, Charles Nuttens, Maribel Casas, Lea Johanna Bayer, Bennet Huebbe, Worku Biyadgie Ewnetu, Juan Luis Ramirez Agudelo, Bradford D. Gessner, Christof von Eiff, Gernot Rohde

Open Access Original Research

Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections

Yuan-Yuan Li, Yan Chen, Shan Li, Yuan-Yuan Li, Ran An, Xiao-Yun Hu, Wei Jiang, Chun-Yao Wang, Run Dong, Qi-Wen Yang, Li Weng, Jin-Min Peng, Bin Du

Open Access Original Research

Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses

Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A. Metzner, Katie Mycock, Hannah Wallis, Andrew P. Brogan, Jimena Patarroyo, Alan Oglesby

Open Access Original Research

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study

Stefan Schneider, Gary Blick, Christina Burke, Douglas Ward, Paul Benson, Franco Felizarta, Dallas Green, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A. Metzner, Katie Mycock, Hannah Wallis, Jimena Patarroyo, Andrew P. Brogan, Alan Oglesby

Open Access Original Research

Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany

Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Scholz, Wolfgang Greiner, Oliver Damm

Open Access Review

Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies

Germaine Hanquet, Christian Theilacker, Jeffrey Vietri, Ingrid Sepúlveda-Pachón, Sonia Menon, Bradford Gessner, Elizabeth Begier

Open Access Study Protocol

Effect of Infusion Set Replacement Intervals on Central Line-Associated Bloodstream Infection in the Intensive Care Unit: Study Protocol of the INSPIRATION Study

Dandan Xu, Chang Hu, Jie Xiong, Haiyan Huang, Shasha Wang, Xinbo Ding, Junying Zhou, Juan Deng, Chunling Guo, Miqi Li, Ting You, Wei Cheng, Bo Li, Xiaoqin Tang, Xiaohong Li, Hongmei Li, Jin Li, Jing Ma, Meng Xiao, Xing Fu, Huilin Li, Zhiyong Peng, Bo Hu, Fen Hu

Open Access Study Protocol

Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol

Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, Charles Nuttens, Thao Mai Phuong Tran, Bradford D. Gessner, Elizabeth Begier

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.